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Cervical cancer in developed countries remains as a major concern on public health policies due to
incidence and mortality rates. Persistent infection with high risk human papillomavirus is a necessary
etiological agent in the progression to invasive cervical carcinoma. A proposed hypothesis is the
association between more aggressive HPV variants and the risk to develop cervical cancer. In order to
have a global perspective in terms of cellular transcripts and molecular pathways affected by HPV18 E6
intratype variants; we conducted a genome wide analysis of gene expression. Our results show that E6
derived from non-European variants are able to up-regulate cellular transcripts associated to the
hallmarks of cancer; such as cell cycle, migration, Wnt pathway and mTor signaling. Moreover, we were
able to show that HPV18 E6 from African variant had a major effect on cellular processes such as cell
cycle and migration as conﬁrmed by functional studies.
& 2012 Elsevier Inc. All rights reserved.Introduction
Cervical cancer (CC) is second only to breast cancer as the most
commonmalignancy in women in both incidence andmortality, with
the highest rates in the developing world. In low-income countries CC
causes at least 200,000 deceases every year. Moreover, in some
countries, CC is the main cause of death in reproductive-aged and
economically active women whose have limited access to earlyll rights reserved.
, FES-IZTACALA, Universidad
e Los Barrios S/N, Los Reyes
(V. Fragoso-Ontiveros),
e.vaca@gmail.com
(L. Alonso Herrera),
s.pplas@gmail.comdiagnosis and effective treatment (Parkin et al., 2005; Arbyn et al.,
2011).
Human Papilloma Virus (HPV) is the major etiological agent
causing CC by persistent infection, where speciﬁc types of high-risk
human papillomaviruses (HR-HPVs) are essential for the progression
of cervical lesions (Londesborough et al., 1996). High-risk HPVs (HR-
HPV), particularly types 16 and 18, are the most frequent variant
types in cancer biopsies worldwide, with nearly one half of all CC
the former, and 15% the latter (Mun˜oz et al., 2003). At present, more
than 120 HPV genotypes have been associated with human infec-
tions (Bernard et al., 1994), 40 of which infect the genital epithelia
(Mun˜oz et al., 2003). Intratypic molecular variants of HPVs are
identiﬁed by differences in nucleotide sequence from the prototype
isolates, stated as less than 2% in the coding regions and 5% for the
non-coding sequence of the viral genome, are deﬁned as molecular
variants or lineages for a speciﬁc strain (Bernard et al., 1994). Thus,
different natural variants for several types of HPV have been
characterized. Variants are classiﬁed and designated according to
the related geographical location (Calleja-Macı´as et al., 2004, 2005;
Stewart et al., 1996)
Table 1
Top 30 up-regulated genes in HaCat Cells by HPV18 E6 AsAi expression.
Gene symbol Gene name Fold changea
LAPTM4A lysosomal protein transmembrane 4 alpha 32.2
LOC440927 similar to ribosomal protein P1 isoform 2 17.8
MARCKSL1 MARCKS-like 1 12.0
OASL 20-50-oligoadenylate synthetase-like 9.3
LOC387753 Not found 8.5
FLJ20582 Not found 7.7
PSMD12 proteasome (prosome, macropain) 26S subunit 7.6
LOC388545 similar to Zinc ﬁnger protein 216 6.8
MIF macrophage migration inhibitory factor 6.5
SSR4 signal sequence receptor 6.3
KIF20B kinesin family member 20B 6.2
LOC441099 similar to beta-glucuronidase 6.2
LOC341604 Not Found 6.1
LDHB lactate dehydrogenase B 6.0
FTHL11 heat shock 105 kDa/110 kDa protein 1 5.9
HSPH1 heat shock 105 kDa/110 kDa protein 1 5.5
MON2 MON2 homolog (S. cerevisiae) 5.4
SLTM SAFB-like, transcription modulator 5.3
NME2 non-metastatic cells 2, protein (NM23B) 5.2
TXNDC17 thioredoxin domain containing 17 5.2
PPIAL4A peptidylprolyl isomerase A (cyclophilin A) 5.1
CCT3 chaperonin containing TCP1, subunit 3 5.0
RPS27A ribosomal protein S27a 5.0
LOC388954 similar to 40S ribosomal protein SA (p40) 4.9
C12orf23 Not Found 4.8
CLASP2 cytoplasmic linker associated protein 2 4.7
MAN2A1 mannosidase, alpha, class 2A, member 1 4.7
WDR24 WD repeat domain 24 4.6
PDLIM1 PDZ and LIM domain 1 4.5
MED4 mediator complex subunit 4 4.5
a Fold change was calculated using 2^Log 2R obtained from the original Log 2R.
Table 2
Top 30 up-regulated genes in HaCat Cells by HPV18 E6 Af expression.
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molecular evidence associated to differences in epidemiological,
clinical and pathological mechanisms present in HPV variants
(Giannoudis and Herrington 2001; Rose et al., 1997; Xi et al., 1997).
These differences are clearer in HPV16 genotypes, probably due to the
higher prevalence of HPV16. Several studies have shown dissimila-
rities between HPV16 variants in association with CC (Bernard et al.,
1994; Berumen et al., 2001; Lizano et al.; 2006; Tidy et al., 1989). For
instance, intratypic variation of HPV16 has been associated as a
predictor of progression to higher grades of cervical lesions (Xi et al.,
1997).
HPV 18 presents three intratypic branches varieties, which are
distributed worldwide as Asian-Amerindian (AsAi), African (Af)
and European (Ong et al., 1993). Molecular and epidemiological
data points that non-European variants of HPV 16 and 18 are
associated with an increased risk of persistent infection and
development of cervical lesions (Berumen et al., 2001; De Boer
et al., 2005; Lizano et al., 1997; Tornesello et al., 2004; Villa et al.,
2000; Xi et al., 1997). Accordingly, Xi et al. have shown that it is
likely to develop a high grade cervical intraepithelial neoplasia for
those patients with HPV18 Af variants (Xi et al., 2007). Therefore,
the epidemiological evidence suggest a direct biological conse-
quence on variations in HPV18 genomes on the overall process of
carcinogenesis, however the involved molecular events are
unclear. The aim of our study was to identify, in a comprehensive
way, cellular transcripts and biological processes differentially
regulated by HPV18 non-European molecular variants in a pre-
neoplastic model, in an effort to characterize early events reg-
ulating the pathway to carcinogenesis in CC. HaCat cell line has
been employed elsewhere as an early neoplastic progression
model, because it is an immortalized but partially transformed
cell line, unable to produce tumors as xenografts (Gille et al.,
2000; Karen et al., 1999). Here we employed it to investigate
which cellular transcripts and molecular processes could be
differentially induced by African and Amerindian HPV18 varieties.Gene
symbol
Gene name Fold
changea
FAM76A family with sequence similarity 76, member A 19.9
C2orf3 Not found 15.5
NUDT13 nudix (nucleoside diphosphate linked moiety X) 14.4
SERPINB2 serpin peptidase inhibitor, clade B, member 2 14.0
ZNF205 zinc ﬁnger protein 205 13.4
FKBPL FK506 binding protein like 13.3
PDE12 phosphodiesterase 12 11.3
PTTG1 pituitary tumor-transforming 1 9.6
LOC390937 Ets2 repressor factor-like 9.3
WNT16 wingless-type MMTV integration site family, 16 8.8
SERPINB5 serpin peptidase inhibitor, clade B, member 5 8.7
LOC441100 Data not found 8.6
RNFT2 ring ﬁnger protein, transmembrane 2 7.4
DHX57 DEAH (Asp-Glu-Ala-Asp/His) box polypeptide 57 7.0
UTP14A UTP14, U3 small nucleolar ribonucleoprotein A 6.9
SPON2 spondin 2, extracellular matrix protein 6.1
KCTD11 potassium channel tetramerisation domain 11 5.7
PPM2C protein phosphatase 2C, magnesium-dependent,
catalytic subunit
5.5
LOC441463 Data not found 5.4
DKK1 dickkopf 1 homolog (Xenopus laevis) 5.4
SLC7A2 solute carrier family 7 (cationic amino acid
transporter, yþ system)
5.4
PDIK1L PDLIM1 interacting kinase 1 like 5.2
RBM3 RNA binding motif (RNP1, RRM) protein 3 5.2
VPS18 vacuolar protein sorting 18 homolog (S. cerevisiae) 5.1
SH3BGRL3 SH3 domain binding glutamic acid-rich protein 3 5.0
LOC91137 Data not found 5.0
RPS6KB1 ribosomal protein S6 kinase, 70 kDa, polypeptide 1 4.9
CALM2 calmodulin 2 (phosphorylase kinase, delta) 4.9
RPL7 ribosomal protein L7 4.9
HIST1H2BH histone cluster 1, H2bh 4.8
a Fold change was calculated using 2^Log 2R obtained from the original Log 2R
table.Results
Transcriptional proﬁles induced by HPV18 E6 Asian-Amerindian and
African isolates
In order to have a comprehensive analysis of cellular transcripts
altered after HPV18 E6 Asian-Amerindian and African isolates expres-
sion in a preneoplastic model, we used HaCat cell line as a
keratinocyte immortalized human cell line. The evaluation of the E6
(AA or AsAi isolates) expression level in cells was carried out by RT-
PCR 48 h after infection, observing a very high amount of E6 mRNA in
the infected cells (Supplemental Fig. 1). Hence, after feature extraction
and normalization, as described in methods, we obtained 12,462
well-measured unique genes. To identify genes with signiﬁcant
changes we selected those genes with a differential expression cut-
off of 1.5-fold, hence E6 Af differentially altered the expression of
2236 genes (880 and 1356 up- and down-regulated, respectively)
from which 678 and 1050 were known and well annotated genes,
respectively. Meanwhile E6 AsAi altered the expression of 1945 genes
(742 and 1202 up and down regulated, respectively) corresponding to
587 and 947 known and well annotated genes, respectively.
Tables 1 and 2 reﬂect the most up regulated genes with higher
changes induced by HPV18E6 Af and HPV18E6 AsAi, respectively.
Those results indicate that HPV18 E6 isolates had preferably negative
effect on cellular gene expression.
Our analyses showed that both HPV18 E6 variants were able to
affect the level of several common transcripts. We used Microsoft
Access to correlate common transcriptional programs induced on
HaCat by both E6 Af and AsAi HPV18 isotypes. Thus, we found that
Table 3
Over-expressed genes common to Af and AsAi variants.
Gene
symbol
Gene name Fold
changea
FKBPL FK506 binding protein like 5.6
DKK1 dickkopf 1 homolog 4.5
PPM2C protein phosphatase 2C, magnesium-dependent,
catalytic subunit
4.3
FLJ20582 Data not found 4.1
LOC387753 Data not found 3.9
PSMD12 proteasome (prosome, macropain) 26S subunit, non-
ATPase, 12
3.6
NT5C2 50-nucleotidase, cytosolic II 3.6
C14orf108 Data not found 3.6
PGAM2 phosphoglycerate mutase 2 3.5
SUCLA2 succinate-CoA ligase, ADP-forming, beta subunit 3.5
LOC390107 Data not found 3.4
RBM3 RNA binding motif (RNP1, RRM) protein 3 3.4
TXNDC17 thioredoxin domain containing 17 3.4
LDHB lactate dehydrogenase B 3.3
ZSCAN29 zinc ﬁnger and SCAN domain containing 29 3.3
H2BFS H2B histone family, member S 3.2
MIF macrophage migration inhibitory factor
(glycosylation-inhibiting factor)
3.0
LOC389156 Data not found 3.0
FABP5 fatty acid binding protein 5 3.0
LOC388954 similar to 40S ribosomal protein SA (p40) 3.0
RPL7 ribosomal protein L7 2.9
OGFOD1 2-oxoglutarate and iron-dependent oxygenase
domain containing 1
2.9
NMD3 NMD3 homolog (S. cerevisiae) 2.9
LOC390294 heterogeneous nuclear ribonucleoprotein A/B 2.9
MIS12 MIND kinetochore complex component 2.8
CLASP2 cytoplasmic linker associated protein 2 2.8
PSAT1 phosphoserine aminotransferase 1 2.7
PAPOLA poly(A) polymerase alpha 2.7
IFT27 intraﬂagellar transport 27 homolog (Chlamydomonas) 2.7
EIF4A1 eukaryotic translation initiation factor 4A1 2.7
a Fold change was calculated using 2^Log 2R obtained from the original Log 2R
table.
Table 4
Down-regulated genes common to Af and AsAi variants.
Gene
symbol
Gene name Fold
changea
SAA1 serum amyloid A1 13.4
NDUFV1 NADH dehydrogenase (ubiquinone) ﬂavoprotein 1,
51kDa
11.5
AKR1C2 aldo–keto reductase family 1, member C2 11.2
COX15 COX15 homolog, cytochrome c oxidase assembly protein 10.9
RPS2 ribosomal protein S2 9.8
LOC91561 Data not found 9.8
FTHL2 ferritin, heavy polypeptide 1 pseudogene 2 9.8
FTL Ferritin, light polypeptide 9.7
RPL32 ribosomal protein L32 9.2
ND4 NADH dehydrogenase subunit 4 8.3
C3 complement component 3 7.8
SAA2 serum amyloid A2 7.7
RPS17 ribosomal protein S17 7.5
PPFIBP2 PTPRF interacting protein, binding protein 2 7.4
IGFBP3 insulin-like growth factor binding protein 3 7.3
PDZK1IP1 PDZK1 interacting protein 1 7.2
RPS18 ribosomal protein S18 7.2
LOC441013 Data not found 6.6
S100A8 S100 calcium binding protein A8 6.5
AKR1C1 aldo–keto reductase family 1, member C1 6.3
RPS28 ribosomal protein S28 6.3
RPL35A ribosomal protein L35a 6.2
RPL41L Data not found 6.2
SEC22L2 SEC22 vesicle trafﬁcking protein homolog A 5.8
WFDC2 WAP four-disulﬁde core domain 2 5.7
IDH3G isocitrate dehydrogenase 3 (NADþ) gamma 5.5
AKR1C3 aldo–keto reductase family 1, member C3 5.2
RTBDN retbindin 5.2
COX3 cytochrome c oxidase subunit III 4.2
EPAS1 endothelial PAS domain protein 1 4.5
a Fold change was calculated using 2^Log 2R obtained from the original Log 2R
table.
V. Fragoso-Ontiveros et al. / Virology 432 (2012) 81–90 83both variants up-regulated 188 common transcripts corresponding to
149 known genes and 226 (188 known genes) were commonly
down-regulated. Tables 3 and 4 list the most signiﬁcantly common
up and down regulated genes induced by both HPV18 genotypes,
indicating that there is a transcriptional program regulated by HPV18
E6 protein, without consideration of a speciﬁc variant.
Pathway analysis
One of our objectives was to translate such lists of signiﬁcant
differentially expressed genes into a better understanding of the
underlying biological phenomena; therefore, genes that changed at
least 1.5 fold were submitted to the visualization tool Pathway
Express (PE, a component of Onto-Tools suite). This bioinformatic
tool is employed for visualizing expression data in the context of
KEGG (Kyoto Encyclopedia of Genes and Genomes) biological path-
ways. The importance of PE is that the impact factor (IF) of the entire
pathway involved can be obtained, which is relevant for a clearer
notion of the alteration level in each biological pathway (Khatri et al.,
2005). IF is calculated for each pathway incorporating parameters
such as the normalized fold change of the differentially expressed
genes, the statistical signiﬁcance of the set of pathway genes, and the
topology of the signaling pathway which can help to obtain a clearer
notion of the alteration level in each biological pathway (Draghici
et al., 2007).
Fig. 1 shows an overview of differentially expressed biological
pathways, as expected, both HPV18 E6 isolates are able to alter theexpression level of genes participating in cancer pathways; however,
there are subtle differences between them. Noteworthy, African
intratype was able to accentuate cellular pathways that are hallmarks
of cancer such as cell migration, cell cycle, DNA replication, mTOR
signaling and Wnt signaling pathway. Figs. 2 and 3 depict speciﬁc
genes activated on cell cycle and Wnt signaling pathway after the
exogenous expression of HPV18 E6 isolates, as can be seen, both
molecular variants are able to induce common cellular genes (red
boxes).HPV18 E6 African variant produces infected cells with a higher
potential of cell proliferation and migration compared to
Asian-Amerindian variant
In order to correlate how changes at expression level and pathway
analyses have effect on cellular processes, we searched for two
important hallmarks of cancer: cell proliferation and migration. The
sulforhodamine b (SRB) assay was employed to analyze differences in
cell proliferation. SRB assay has the enough sensitivity to analyze
within a linear dynamic range over densities of 7500–180,000 cells
per well on 96-well plaques (Vichai and Kirtikara, 2006; Murray et al.,
2008). Hence, we were able to observe that HPV18 E6 Af variant
induces a small icrement in cell proliferation (Fig. 4) compared to
AsAi variant. Moreover, we compared the migration of (i) HaCat cells
with pCDNA empty vector, (ii) HaCat cells producing HPV18 E6 Af
variant proteins and, (iii) HaCat cells producing HPV18 E6 AsAi
variant proteins. This was done using a scratch assay. At 16 h,
migration was signiﬁcantly increased by E6 from Af variant in
comparison to AsAi, as depicted in Fig. 5a and b.
Fig. 1. KEGG-based metabolic pathways to be over-expressed by HPV18 E6 Af and AsAi variants. To have an overview of cellular processes affected by both variants,
signiﬁcant over-expressed genes were up-loaded to Pathway Express, thus the Impact Factor retrieved for each KEGG-term was graphed. Impact Factor as expressed on
logarithmic arbitrary units.
Fig. 2. Genes mapping to KEGG pathway Cell Cycle. Enrichment analysis of genes associated to Cell Cycle, up-regulated transcripts induced by Asian-Amerindian are
depicted in aqua boxes on this map. While African induced cellular transcripts are represented by red boxes. Induced transcripts by both variants are green boxes.
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Fig. 3. Genes mapping KEGG WNT signaling pathway. Enrichment analysis of genes associated to Wnt signaling, up-regulated transcripts induced by Asian-Amerindian
are depicted in aqua boxes on this map. While African induced cellular transcripts are represented by red boxes. Induced transcripts by both variants are green boxes.
(For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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samples
In order to correlate microarray data with protein expression,
we chose the most over and down-regulated common transcripts
(Tables 3 and 4) to search for immune-staining on CC tissue samples;
therefore, we consulted the Human Protein Atlas database (http://
www.proteinatlas.org/), which has information on protein expression
in about 24 CC samples. DKK1 and PSMD12 (Table 3, top over-
expressed genes), protein expression showed a predominant cyto-
plasmic/membranous presence mainly on CC epithelial cells. Staining
for DKK1was expressed fromweak to strong in the majority of tumor
samples, only 17% of tissues were negative (Fig. 6a left). Respecting to
PSMD12 showed a staining from weak to moderate, only 8% of CC
samples were negative (Fig. 6b left). In both the cases normal cervices
biopsies showed a lesser immunoreactivity in comparison to tumor
biopsies (Fig. 6a and b right). NDUFV1 was no detected in the
majority of analyzed tumor samples (Fig. 6c left). Staining for
NDUFV1 was weak positive for 25% of CC samples, whereas com-
pletely negative for 75% of cervical carcinomas. On the other hand,
NDUFV1 showed a cytoplasmic positive staining from weak to
moderate in normal cervical tissue samples analyzed (Fig. 6c right).
Several genes from each category were chosen for further analyses
as shown in Supplemental Fig. 2. Real time PCR was performed using
gene speciﬁc primers. As expected, all observations made by micro-
array experiments were conﬁrmed using real time PCR.Discussion
In this work we have shown differentially expressed tran-
scripts and cellular pathways induced by HPV 18 E6 from African
and Asian-Amerindian variants using HaCat cell as a premalig-
nant model. Our main focus was to characterize early events
regulating the pathway to carcinogenesis in CC; thus, we used
the HaCat cell line as a validated early neoplastic progression
model, because is an immortalized but partially transformed
cell line, unable to produce tumors as xenografts (Gille et al.,
2000; Karen et al., 1999). The principal objective was to explore
cellular transcripts and molecular processes affected by both
variants on a premalignant model of carcinogenesis.
Therefore, by means of a microarray containing 45,000 cellular
transcripts corresponding to virtually the whole genome tran-
scriptome, we were able to identify speciﬁc genes and cellular
pathways related to an early carcinogenesis process that
were affected by both Af and AsAi E6 HPV18 variants. To our
knowledge, this work constitutes the ﬁrst comprehensive
study showing the impact on cellular processes affected by the
major HPV18 variants associated to cervical carcinogenesis
development.
As expected, signiﬁcant cellular pathways related to carcino-
genesis process were upregulated by both variants of HPV18 E6
protein. Hence, genes belonging to cell cycle, DNA replication,
mTOR, Wnt/beta-catenin, transendothelial leukocyte migration
Fig. 5. The effect of E6 HPV18 variants on HaCat cell migration in a scratch wound
healing assay. (a) Conﬂuent monolayers of HaCat cell transfected either with
empty vector (pCDNA) or African (Af) or Asian Amerindian (AsAi) variants. The
wounded areas of the cell monolayer were observed by phase-contrast micro-
scopy and photographed after 6 or 16 h. (b) Graphical representations of wound
healing experiment described here. Migrated area is represented by arbitrary units
obtained from NIH image software (Image J-64).
Fig. 4. HPV18 E6 Af and As-Ai have a differential effect on cellular proliferation.
After E6 transfection to HaCat cells, cell proliferation was determined by SRB
assay. pCDNA empy vector was used as proliferation control. Af, African variant.
AsAi, Amerindian variant.
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both viral intra-types. However, HPV18 E6 African had a slightly
higher effect on the impact factor calculated for those cell path-
ways (Fig. 1).
In the context of changes in expression proﬁle induced by
E6/E7 from high risk HPV, Garner-Hamrick and colleagues
employed an organotypic keratinocyte culture system and
showed a signiﬁcant alteration on 1381 genes. Gene ontology
enrichment analyses demonstrated that E6/E7 induced genes that
participate in cell cycle, intracellular signaling and DNA synthesis
(Garner-Hamrick et al., 2004). In the same way, Duffy and co-
workers (2003) have used oligo expression arrays to identify
global alterations in gene expression induced by E6 in a kerati-
nocyte previously transfected with E7. Their ﬁndings showed that
mainly the genes associated to keratinocyte differentiation pro-
cess were down-modulated by E6 in the context of E7. Also, they
discovered genes associated to cell cycle control and immune
response, concordantly with our results (Duffy et al., 2003).
Clearly, global expression experiments demonstrate that HPV
oncoproteins are able to increase the expression of genes related
to DNA synthesis and coordinate cell cycle induction, thus,
increasing the productive life cycle of HPV.
The mammalian target of rapamycin (mTOR) is a central
controller of cell growth and proliferation, hence involving several
molecular processes such as protein, membrane lipids and nucleic
acid synthesis. mTOR controls carbohydrate metabolism regulat-
ing glycolysis, gluconeogenesis and also it is involved in apoptosis
evasion and cytoskeleton reorganization. mTOR pathway has
been reported as over-activated in a wide range of tumor cells
and is considered as a hallmark of cancer (Hanahan and
Weinberg, 2011). Some reports have shown that mTOR could
play an important role in CC clinical outcome; to this respect Kim
and co-workers showed that CC patients staged IIB-IVA with a
worse outcome were signiﬁcantly associated to activated mTOR
expression; showing that high expression of activated mTOR was
associated to radiation resistance (Kim et al., 2010). In vitro
studies have shown that mTOR is activated in HeLa CC cells and
its inhibition suppressed cell cycle and increase apoptosis (Ji and
Zheng, 2010). Here, we have shown that HPV18 E6 could activate
mTOR signaling pathway (Fig. 1), additional work should be done
to give more evidence.
One of the most differentially affected pathways was the
transendothelial leukocyte migration, which was three-times
enriched by HPV18 E6 African isolate, in comparison to Asian-
Amerindian intra-type. The passage of cancer cells across the
endothelium or transendothelial migration (TEM) is a crucial step
in metastasis formation. Such a process is similar to leukocyte
diapedesis extravasation; which involves transient, selectin-
mediated interactions followed by ﬁrm adhesion via integrins
that are activated by locally produced chemokines (reviewed at
Miles et al. (2008)). Several classes of molecules that mediate
diapedesis, including chemokines and their receptors, E-selectin
and integrins, have been related to cancer cell extravasation and
metastasis (Giavazzi et al., 1993; Mu¨ller et al., 2001; Voura et al.,
2001). Moreover, cell junction proteins, including cadherins, have
been implicated in melanoma cell transendothelial migration
(Qi et al., 2005). Over-expressed genes that are part of
transendothelial leukocyte migration pathway, and were over-
expressed by HPV 18 E6 Af variant, were ARHGAP5, OCLN, VCL,
PTPN11, ITGB1 and ACTG1. Those genes are known to play key
roles in the process of migration, diapedesis and cell trafﬁcking
(Gen et al., 2009; Fletcher et al., 2012; Dumbauld et al., 2010;
Wang et al., 2009).
In order to get an insight of the ability to migrate of both Af
and AsAi HPV18 E6 transfected HaCat cells, it was performed
wound-healing (scratch) assays (Liang et al., 2007; Rodrı´guez
Fig. 6. Immuno-staining for over-induced and down-regulated genes on cervix tissue samples. Immuno-detection appears as a brownish stain on the slide surface.
Representative image of protein expression on CC tissue samples (left panel) and normal cervical epithelia (right panel) for common top expressed genes (a) DKK1,
(b) PSMD12 and tumor down-expressed (c) NDUFV1. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this
article.)
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of HPV18 Af transfected cells compared to empty-vector and AsAi
variant, quantiﬁed by measuring the remaining open area of the
scratch using NIH ImageJ software after 16 h (Fig. 5). These
studies show the relevance of transcriptome analyses and the
signiﬁcance that have molecular pathway analysis on complex
cellular responses, as are illustrated by proliferation and migra-
tion assays (Figs. 1, 2, 4 and 5).
We and others have conﬁrmed that Wnt signaling pathway is
activated during CC progression (Pe´rez-Plasencia et al., 2007,
2008; Lichtig et al., 2010; Bonilla-Delgado et al., In press). Here,
we demonstrated that HPV18 E6 expression induced in an early
neoplastic progression model (HaCat cells) concordantly could
activate Wnt signaling pathway. Interestingly, in this preneoplas-
tic model, activation of Wnt pathway is achieved by upstream
regulators such as FZD, Wnt, FRAT1 and 2. FRAT genes belong to
GSK-3-binding protein family which are potent activators of Wnt
signaling pathway, moreover, several reports showed its activa-
tion in distinct tumors (reviewed at van Amerongen and Berns
(2005)). Data presented in the present work, strengthens the
hypothesis of up-regulation of wnt/beta-catenin signaling path-
way as a ‘‘second hit’’ required to develop cervical cancer.Furthermore, it seems that Wnt activation is an early event
towards malignancy and can be achieved by activating upstream
regulators of the pathway. E6 and E7 are able to interact with a
plethora of cellular proteins affecting the cellular pathways
required to normal architecture maintenance. A seminal work
(Uren et al., 2005) showed that induced malignant transformation
of keratinocytes infected with high risk, the activation of canoni-
cal Wnt signaling through inactivation of phosphatase, PP2A plays
a central role.
To validate our microarray and pathway analyses results, we
employed not only cellular techniques to analyze global processes
such as migration and cell cycle; but also we used real time PCR
(supplementary Fig. 2) and available databases. To this concern,
we consulted the Human Protein Atlas database to search for
protein expression on CC tumor samples looking for DKK1 and
PSMD12 (top over-expressed genes in Table 3) and NDUFV1 and
AKR1C2 (top down-regulated genes in Table 4) conﬁrming micro-
array results. The importance of this analysis was the examina-
tion of cellular genes affected after transgene expression of
oncoprotein E6; therefore, the transcriptional change induced in
our cellular model can be observed and is also reproducible in the
CC tumor samples.
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variant is predominantly associated to adenosquamous CC (ADC),
whereas the African variant was associated with squamous cell
carcinomas (SCC) (De Boer et al., 2005). Interestingly, ADC
patients have a slightly worse prognosis than SCC tumors (1.27
of relative risk) (Lai et al., 1999), showing that small nucleic-
sequence differences could have an important impact on the
pathogenesis of CC (De Boer et al., 2005). Unfortunately, there are
few functional studies revealing the impact of HPV18 variants on
cervical carcinogenesis process (Lo´pez-Saavedra et al., 2009).
Contreras-Paredes et al. (2009) showed molecular differences
induced by AsAi and Af variants on activation of PI3K/AKT path-
way. In this work we have shown that E6 from HPV18 Af and AsAi
induced differences not only in cellular transcripts and cellular
pathways, but also in global cellular processes such as cell
migration and cell cycle. Besides, we presented data to point that
E6 derived from HPV18 African variant has a major impact on
cellular processes driven to carcinogenesis process on a preneo-
plastic model in respect to Asian-Amerindian. However, more
studies are needed to evaluate the global impact that could have
the complete HPV18-intratype genomes on molecular and cellu-
lar mechanisms associated to carcinogenesis.Materials and methods
Cell culture and transfection
HaCat human keratinocyte derived cell line was grown in
Dulbecco’s modiﬁed Eagle’s medium (DMEM-F12, GIBCO-BRL)
supplemented with 8% fetal bovine serum (FBS). Transient
transfections were carried out in HaCat with 4 ug DNA from
either empty vector (pCDNA3.1) or vectors harboring E6 variant
genes from African (Af) or Asian Amerindian (AsAi) HPV18
isolates as previously were described by Contreras-Paredes et al.
(2009). Brieﬂy, transfections were performed with lipofectamine
2000 (Gibco-BRL Grand Island, NY, USA) as recommended by
manufacturer.
Semi quantitative RT-PCR
After 24 and 48 h transgene expression was analyzed by PCR
ampliﬁcation and sequencing. Total RNA was puriﬁed using
RNeasy Mini Kit (QIAGEN, Duesseldorf, Germany). One mg of
RNA was used to synthesize cDNA using High Capacity cDNA
Reverse transcription kit (Applied Biosystems). This cDNA was
used as a template to perform a PCR reaction using as primer
forward 50ATGGCGCGCTTTGAGGATCCAACA-30 and as reverse
50–TACTTGTGTTTCTCTGCGTCGTTG-30 amplifying the full length
of HPV18 E6 gene.
Microarray processing and data analysis
Each microarray experiment was performed as triplicates. To
discriminate the effect that the pCDNA 3.1 vector had on the
cellular gene expression, we compared the expression proﬁle of
vector-empty transfected cells versus HPV18 E6 Af or AsAi
transfected cells. Hence, 1 ug of total RNA was employed for
cDNA synthesis and labeled using Amino Allyl MessageAmp II
aRNA Ampliﬁcation Kit (Ambion Inc, Austin, TX, USA) following
manufacturer instructions. mRNA obtained 24 h after transfection
from cells with empty vector, were labeled with Cy3, whereas
either cells carrying E6 variant genes from African (Af) or Asian
Amerindian (AsAi) were Cy5 labeled. Dye incorporation efﬁciency
was analyzed measuring Cy’s speciﬁc absorbance. 500 pmol of
each dye were hybridized onto Human Exonic Evidence Basedoligonucleotide (HEEBO) arrays obtained from the Stanford Func-
tional Genomics Facility (Stanford, CA). Each microarray con-
tained 43,000 spots, including 85.8% I.M.A.G.E. consortium
clones from the Research Genetics Sequence Veriﬁed clone set
(http://www.invitrogen.com/content/sfs/manuals/sequenceveri
ﬁedclones_man.pdf), 9.8% CGAP clone set (http://cgap.nci.nih.gov/
Genes/PurchaseReagents), and 4.4% control spots, corresponding
to 18,141 mapped human genes. Hybridization was performed at
42 1C for 18 h. Following hybridization, arrays were washed and
scanned using a GenePix 4100A Axon scanner (Axon Instruments,
Union City, CA). Fluorescence ratios were extracted using GenePix
5.0 software (Axon Instruments, Union City, CA). We deﬁned well-
measured spots by (1) having a ratio of normalized signal
intensity to background noise of 42 for either the Cy5 signal
derived from Af or AsAi transfected cells, or the Cy3 signal derived
from empty vector transfected cells and (2) with no ﬂag assigna-
tion by GenePix software which corresponds to a bad spot quality
caused by not reliable hybridization and corruption by noise. We
performed an algorithm on Microsoft Excel to accomplish both
conditions (supplementary information ﬁle 1). Background-sub-
tracted ﬂuorescence log 2 ratios were globally normalized for
each array, and then mean-centered for each gene. Each micro-
array experiment was repeated three times as technical replicates
for statistical robustness. Finally, to avoid bias caused by different
properties of the two cyanine dyes (Kerr and Churchill, 2001) it
was balanced the intensity level of both channels using LOWESS
normalization method included on ArrayNorm software (Pieler
et al., 2004)
Analysis of array data
To identify cellular processes altered by expression of HPV18
E6 isolates, we used the visualization tool Pathway Express (PE,
a component of Onto-Tools suite). This bioinformatic tool is
employed to visualize data expression in the context of KEGG
(Kyoto Encyclopedia of Genes and Genomes) biological pathways.
The importance of PE is that it retrieves an impact factor (IF) of
the entire pathway involved, which can help to obtain a clearer
notion of the alteration level in each biological pathway (Khatri
et al., 2005). We imported into the program a list of signiﬁcantly
up and down regulated genes which were changed at least two
fold (Additional ﬁle 2), to convert the expression data into
cellular-pathway illustrations in an attempt to explore altered
mechanisms in pre-neoplastic cell line model HaCat expressing
HPV18 E6 AsAi or Af.
Protein expression on tissue microarray
Validation of microarray data was accomplished by means of
analysis on Human Protein Atlas database (HPA), which is a public
available database containing images that show the spatial dis-
tribution of proteins in tissue microarrays using immune-histo-
chemical staining (Uhle´n et al., 2005, 2010). The generated tissue
microarrays include samples from 46 different normal tissue
types from 138 individuals and 20 different types of cancer from
216 patients (http://www.proteinatlas.org/). Hence, selected
genes obtained from the most representative Up and Down-
regulated table, were searched for protein expression on CC tissue
microarray samples. We examined the expression levels of FKBPL,
DKK1, PSMD12, SAA1, and NDUFV1 proteins on HPA database;
however, it was not found information for FKBPL and SAA1
protein expression. The selected antibodies reported on http://
www.proteinatlas.org/ were CAB009726 for DKK1, HPA023119
for PSMD12 and HPA045211 for NDUFV1. Protein expression
analyzed on CC tissue samples and normal cervical epithelia
was reported as intensity of immune-staining (negative, weak,
V. Fragoso-Ontiveros et al. / Virology 432 (2012) 81–90 89moderate and strong) and staining intensity as the percentage of
stained cells (rare, o25%, 25%–75% or 475%); moreover, sub-
cellular localization (nuclear and/or cytoplasmic/membranous)
was indicated.
Quantitative reverse transcription PCR (RT-qPCR)
RNA from recombinant cells was obtained after using Trizol,
and the samples were then treated with DNase I before RT-PCR
according to the manufacturer’s recommendations (Roche). Com-
plementary DNA (cDNA) was generated by High Capacity cDNA
Reverse transcription kit (Applied Biosystems). The RT reaction
was incubated at 25 1C for 10 m, 37 1C for 2 h and, 85 1C for 5 m.
The cDNA was stored at 20 1C for subsequent quantitative PCR
ampliﬁcation, gene transcripts were quantiﬁed by real-time PCR
using the LightCycler 2.0 (Roche) and were detected with Light-
Cycler FastStart DNA MasterPLUS SYBR Green as indicated by the
vendor. Gene sequences for primer design were obtained from the
NCBI Reference Sequences database (http://www.ncbi.nlm.nih.
gov/RefSeq/). Primers were chosen using the Primer3 software
(http://www.broad.mit.edu/cgi-bin/primer/primer3_www.cgi).
Primer sequences are provided in the supplemental material
(supplementary online Table 1). Primers were ordered and
synthesized at Invitrogen Life Technologies. The relative expres-
sion changes were determined with the 2-DDCT method, and the
housekeeping glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) gene transcript was used to normalize the results. PCR
efﬁciency was tested for each primer pair by dilution series of
cDNA to make sure that the efﬁciency was appropriate for the
2-DDCT method (i.e., 95% or above). In order to identify the
ampliﬁcation of any contaminating genomic DNA, and to ensure
the speciﬁcity and integrity of the PCR product, melt-curve
analyses were performed on all PCR products. No products were
obtained with real-time PCR from RNA samples when RT was
omitted. Samples without template were included for each
primer pair to identify contamination.
Proliferation assay
The effect on cell proliferation of HPV 18 E6 AsAi or Af variants
were analyzed by the Sulforhodamine B (SRB; Sigma-Aldrich)
colorimetric assay as reported (Vichai and Kirtikara, 2006).
Brieﬂy, HaCat cells expressing HPV18 E6 AsAi or bearing empty
vector, were seeded at a density of 5103 cells per well in 100 ml
of growth medium supplemented with 10% FBS in a 96-well plate.
Proliferation was determined at 36 h after transfection. Cells were
ﬁxed with 10% trichloroacetic acid (Fisher Scientiﬁc, Loughbor-
ough, UK) for 1 h, washed ﬁve times with tap water, air dried and
stained with 0.4% SRB in 1% acetic acid for 1 h. Following that,
cells were washed with 1% acetic acid, air dried and the SRB stain
was solubilized with 10 mM Tris-base (100 ml per well; Fisher
Scientiﬁc). The absorbance of each well was measured at 565 nm
using an Epoch plate reader (Biotek, Potton, UK). Absorbance
values for HaCat cells bearing pCDNA plasmid was considered as
100% of proliferation.
Scratch wound healing assay
Migration was assessed by wound healing scratch assay as
previously described (Liang et al., 2007); brieﬂy, HaCat cells
expressing HPV18 E6, Af, AsAi, or bearing empty vector were
seeded in triplicate wells of a six well plate and grown to 90%
conﬂuence. A vertical wound was created on the cell monolayer
in each well using a sterile P100 micropipette tip. The wells were
then washed with 1 mL of growth medium, which was removed
and replaced with 3 mL of serum free growth medium.The ﬁrst image of each scratch was acquired at time zero
through an inverted phase contrast microscope (10 magniﬁca-
tion). The 6 well-plate was then incubated at 37 1C, 5% CO2 for
16 h. After that time, each scratch was examined and photo-
graphed at the same location. The scratched area was quantiﬁed
at each time point using NIH image software (Image J-64) and the
resulting values were graphed.
Statistical analysis
When indicated, data was expressed as mean7standard
deviation from triplicate experimental replicates and were ana-
lyzed with Microsoft Excel using Student’s t-test with signiﬁcance
deﬁned as po0.05.Acknowledgments
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